Trastuzumab Deruxtecan Is Safe and Active in HER2-Expressing Tumors [Research Watch]

Trastuzumab deruxtecan achieved responses in patients with breast, gastric, and gastroesophageal tumors.

from Cancer via ola Kala on Inoreader http://ift.tt/2ialZDE
via IFTTT